Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Endocrine, Metabolic & Immune Disorders Drug Targets|September 4, 2018
Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis RevisitedYoshifumi SaishoWorld Journal of Diabetes|February 17, 2015
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetesYoshifumi SaishoVascular Health and Risk Management|April 28, 2015
Alogliptin benzoate for management of type 2 diabetesYoshifumi SaishoJournal of Clinical Medicine|August 4, 2015
Importance of Beta Cell Function for the Treatment of Type 2 DiabetesYoshifumi SaishoThe Review of Diabetic Studies : RDS|December 25, 2016
Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine PancreasYoshifumi SaishoInternational Journal of Molecular Sciences|October 15, 2014
Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?Yoshifumi SaishoInternational Journal of Molecular Sciences|May 20, 2016
Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 DiabetesYoshifumi SaishoInternational Journal of Environmental Research and Public Health|May 12, 2018
Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported OutcomesYoshifumi SaishoDiseases (Basel, Switzerland)|May 15, 2020
SGLT2 Inhibitors: the Star in the Treatment of Type 2 Diabetes?Yoshifumi SaishoExpert Opinion on Pharmacotherapy|June 11, 2020
An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspectiveYoshifumi SaishoPageof 10